Once again unlawful behaviour has not been
reported in a timely manner to the civil authorities — in this case the Charity Commission — who could have taken action to stop it...
Albany and Troy have reportedly been dumping sewage into the Hudson River and not
reporting it in a timely manner.
CDC declined an interview request, saying only that the agency «thanks the IOM for developing
the report in a timely manner and looks forward to reviewing the report.»
The DPMs provide advice and assistance to supervisors, managers, and others on disability employment matters; maintain and submit completed
reports in a timely manner; facilitate management training in consultation with the respective OA Office of Civil Rights or DOCR, as appropriate; and ensure that reasonable accommodation request information is entered into the DOT reasonable accommodation request tracking system [See CHAPTER 7 — INFORMATION AND REPORTS].
WASHINGTON — The U.S. Department of Transportation's National Highway Traffic Safety Administration (NHTSA) today announced that Hyundai has agreed to pay a $ 17.35 million civil penalty and comply with NHTSA oversight requirements outlined in a Consent Order as a result of the manufacturer failing to
report in a timely manner a safety - related defect affecting 2009 - 2012 Hyundai Genesis vehicles.
That professional will prepare an exceptional literature review, assist with development of research methodologies, summarize the results of experiments, analyze data, and produce an original lab
report in a timely manner.
Visa Zero Fraud Liability is another benefit and means you won't be held responsible for unauthorized purchases on your Visa account if
you report them in a timely manner.
Most veterinary specialists are zealous about making sure your primary care veterinarian receives both written and phone call
reports in a timely manner following the animal's most recent specialist visit.
Contacting the insurance company should be the first thing that is done because coverage can be denied in the event the incident was not
reported in a timely manner.
Investigate suspicious activity and
report it in a timely manner, decreasing response time by five minutes and increasing criminal conviction rate by 5 % since 2014
Field Chemist 12/1/2008 — 3/1/2012 Outdoor Chemistry Co. — Seattle, WA Took and analyzed samples from construction sites Tested for moisture, pH and consistency Maintained a field lab Wrote and submitted regular
reports in a timely manner Helped develop cost - effective solutions for potential environmental pollutant issues
Collect, analyze, and summarize case documentation to prepare and write concise and detailed investigation
reports in a timely manner.
Utilized time on shift to complete
all reports in a timely manner while still offering services to the town.
• Accurately gathered documents, regulations, publications, correspondence and
reports in a timely manner to prepare outgoing documents for unit, commander and organization, ensuring documents were proofed and editing as appropriate.
As a company we strive to return
reports in a timely manner (usually within 72 hours), while ensuring maximum possible accuracy of the information concerning the...
Prepared and maintained teacher's diary and student
reports in a timely manner • Organized school and classroom tour for new admissions.
As a company we strive to return
reports in a timely manner (usually within 72 hours), while ensuring maximum possible accuracy of the information concerning the subject of the report.
Work closely with the Finance Manager, Credit Managers, Staff Accountant and other staff members to develop accounting strategy and ensure accuracy of the accounts payable aging
report in a timely manner.
Collaboration and co-operation involves the sharing of information, resources and support to produce
reports in a timely manner and takes place during the production and assessment of research, with frequent consultation.
Not exact matches
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA
in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results
in subsequent clinical trials; regulatory submissions may not occur or be submitted
in a
timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction
in payment rate or reimbursement for the company's products or an increase
in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors»
in the company's most recent Annual
Report on Form 10 - K and
in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Picha said he was notified
in a
timely manner of the most recent discovery
in a new area but didn't
report it to the commission because he thought the pipeline company would.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a
timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's
reports filed with the U.S. Securities and Exchange Commission (the SEC).
In addition to factors previously disclosed in Tesla's and SolarCity's reports filed with the U.S. Securities and Exchange Commission (the «SEC») and those identified elsewhere in this document, the following factors, among others, could cause actual results to differ materially from forward - looking statements and historical performance: the ability to obtain regulatory approvals and meet other closing conditions to the transaction, including requisite approval by Tesla and SolarCity stockholders, on a timely basis or at all; delay in closing the transaction; the ultimate outcome and results of integrating the operations of Tesla and SolarCity and the ultimate ability to realize synergies and other benefits; business disruption following the transaction; the availability and access, in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provision
In addition to factors previously disclosed
in Tesla's and SolarCity's reports filed with the U.S. Securities and Exchange Commission (the «SEC») and those identified elsewhere in this document, the following factors, among others, could cause actual results to differ materially from forward - looking statements and historical performance: the ability to obtain regulatory approvals and meet other closing conditions to the transaction, including requisite approval by Tesla and SolarCity stockholders, on a timely basis or at all; delay in closing the transaction; the ultimate outcome and results of integrating the operations of Tesla and SolarCity and the ultimate ability to realize synergies and other benefits; business disruption following the transaction; the availability and access, in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provision
in Tesla's and SolarCity's
reports filed with the U.S. Securities and Exchange Commission (the «SEC») and those identified elsewhere
in this document, the following factors, among others, could cause actual results to differ materially from forward - looking statements and historical performance: the ability to obtain regulatory approvals and meet other closing conditions to the transaction, including requisite approval by Tesla and SolarCity stockholders, on a timely basis or at all; delay in closing the transaction; the ultimate outcome and results of integrating the operations of Tesla and SolarCity and the ultimate ability to realize synergies and other benefits; business disruption following the transaction; the availability and access, in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provision
in this document, the following factors, among others, could cause actual results to differ materially from forward - looking statements and historical performance: the ability to obtain regulatory approvals and meet other closing conditions to the transaction, including requisite approval by Tesla and SolarCity stockholders, on a
timely basis or at all; delay
in closing the transaction; the ultimate outcome and results of integrating the operations of Tesla and SolarCity and the ultimate ability to realize synergies and other benefits; business disruption following the transaction; the availability and access, in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provision
in closing the transaction; the ultimate outcome and results of integrating the operations of Tesla and SolarCity and the ultimate ability to realize synergies and other benefits; business disruption following the transaction; the availability and access,
in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provision
in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants
in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provision
in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured
in a timely manner, could trigger a default of other obligations under cross-default provision
in a
timely manner, could trigger a default of other obligations under cross-default provisions.
Consumers» ability to repay their debt obligations
in a
timely manner and manage their credit wisely is reflected by their personalized credit score (sometimes known as FICO score), which is derived from the three credit
reporting agencies.
Moreover, the RTTNews
report rightly highlights that this apparent move towards cryptocurrency means that staff working for CheapAir.com really need to be up to scratch with their blockchain knowledge, if they wish to handle complaints and answer queries
in an efficient and
timely manner.
Taking and
reporting inventory to the Head Brewer
in a
timely manner (for ingredients and beer tax purposes)
«By placing a law on the books requiring parents and guardians to
report missing children who are
in significant danger
in a
timely manner, we will ensure for the future that parents are going to be held accountable for their actions.
The Democrat's campaign failed to refund
in a
timely manner an inappropriate contribution it received and
reported several improper post-election -LSB-...]
On more than 12 occasions, Suffolk County probation officers failed to alert prosecutors
in a
timely manner that convicted drunken drivers attempted to drive while under the influence or tampered with court - ordered ignition interlock devices, according to a
report by the state comptroller's office.
When it comes to investing such a substantial amount of taxpayer money, the expectation that updates and
reports will be provided
in a
timely manner should be higher than ever.
The Times Union has
reported that, under the current administration, cops
in Rensselaer County «are not happy» about the number of felony cases that have been dismissed by courts for not being presented to a grand jury
in a
timely manner.
As part of the
report, the town clerk was also faulted for failing to record all purchases
in a
timely manner and for neglecting to prepare accountability analyses.
In at least two instances, the Santa Clara County Democratic Central Committee United Democratic Campaign has accepted large checks from influential state labor unions, but failed to report those contributions in a timely manne
In at least two instances, the Santa Clara County Democratic Central Committee United Democratic Campaign has accepted large checks from influential state labor unions, but failed to
report those contributions
in a timely manne
in a
timely manner.
During the first quarter of 2016, 406 inspections of research facilities were conducted; animal activists say those
reports were generally posted
in a
timely manner.
Administrative: Complete necessary assessments,
reports and records
in an accurate and
timely manner.
Until now, the agency considered whether states evaluated students for special needs
in a
timely manner, whether they
reported information to the federal government and met other procedural benchmarks.
Real - time
reports that help educators assess student progress and make informed instructional decisions
in a convenient and
timely manner.
But the
report shows councils struggling to arrange meetings
in a proper or
timely manner, causing delays to the entire process.
For example, LMS
reports reveal that an individual had trouble completing the task simulation
in a
timely manner.
«When the state fails to provide test scores
in a
timely manner consistent with Tennessee statute, they should waive the accountability requirements for this
reporting cycle automatically without requiring school districts to jump through any additional hoops,» posits Lawson.
Often times, drivers do not
report these changes
in a
timely manner.
OST Budget is responsible for ensuring all of the
reports are cleared and sent to Congress
in a
timely manner.
Buyers
report that they are expecting to be followed up with
in the weeks after the SEMA Show, and it is more important than ever
in this technology age to do so
in a
timely manner so that you are top of mind for buyers who've shown interest
in your products.
- Oversee all incoming and outgoing email and phone communication with customers that have submitted inquiries through the internet - Taking sales calls - Interact with sales staff and management to ensure all telephone and internet leads are handled correctly,
in a
timely and professional
manner - Meticulously track all telephone and internet leads through Internet based Reynolds & Reynolds Contact Management software - Perform monthly
reporting for all sales and lead statistics
StudentsAssignmenthelp.com serves students by providing them all their needed information about the economic world and organizes all information
in the proper and a meaningful
manner for them for their essays,
reports or assignments.StudentsAssignmentHelp.com pushes students for scoring good marks through
timely provided students, their assignments with required quality.
Regardless of the model, before establishing a partnership the Press requires each e-vendor to meet stringent criteria including file security, and routine sales
reporting so that we can compensate our authors
in a
timely and accurate
manner.
Legally, I can challenge any item that appears on my
report, and the
reporting company is obligated to investigate my claim
in a
timely manner.
If the creditor does not respond
in a
timely manner to the
reporting agencies investigation, the credit
report may be revised
in the favor of the consumer.
While the Fair Credit
Reporting Act requires credit bureaus to investigate consumer disputes
in a
timely manner, the law does give them some leeway to stop consumers from abusing the process.
Not this time Vitesse Financial delivers what they promises and
in a very
timely manner... All my clients with glitches on there
reports — 1st stop Vitesse Financial — the savings on their new loans SUBSTANTIAL!!!!! (Your results will vary)